AB, President, CEO, GenomOncology, LLC
Mr. Glynias is a serial entrepreneur with over 25 years of experience in bioinformatics. Immediately prior to GenomOncology, Manuel was a partner at Rosetta, a leading interactive marketing agency, where he helped develop big data solutions for ecommerce clients. In the late 90’s, Manuel was the founder and CEO of NetGenics, a venture-backed provider of discovery informatics to the biopharmaceutical industry and academic research centers. He also developed a number of other commercial software platforms including MacGene, Gene Works, and Primer Express. Manuel has an AB in Biochemistry and Molecular Biology from Harvard College.
Clinical & Research Tools Showcase: GenomOncology, LLC
GenomOncology enables real-time clinical decision-making at the point-of-care for Molecular Pathologists, Clinical Oncologists and Cancer Informaticists in their research of cancer treatments and therapies for cancer patients.
Augmented Intelligence for Precision Oncology
GenomOncology will discuss tools and workflows that enhance the capabilities of human clinical decision-making through real-time application of Artificial Intelligence. We will demonstrate currently available applications for therapy and clinical trial selection, and discuss our early work to utilize deep-learning AI systems to further improve these capabilities.